Pfizer
Pfizer, Novartis, MSD, Novo and GSK halt operations in wake of Hurricane Florence
September 14, 2018Medical Communications GSK, Hurricane Florence, MSD, Novartis, Novo Nordisk, Pfizer, pharma
As Hurricane Florence begins to breach the Southeast Coast, major pharma firms have announced they are enacting contingency plans, including …
Merck KGaA and Pfizer’s combo impresses in first-line treatment of advanced kidney cancer
September 12, 2018Research and Development, Sales and Marketing Cancer, Kidney cancer, Merck KGaA, Pfizer, pharma
Bavencio (avelumab), Merck KGaA and Pfizer’s human anti-programmed death ligand-1 (PD-L1) antibody, combined with the latter’s Inlyta (axitinib) has shown …
Pfizer says Brexit will cost the company $100 million
September 4, 2018Manufacturing and Production EU, Pfizer, UK, brexit, pharma
The US multinational Pfizer has said that Brexit will cost the company $100 million in costs associated with the transference …
The September 2018 issue of Pharmafocus is available to read online now!
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance
The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …
Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines
August 16, 2018Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma
Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …
NICE recommends Pfizer’s Besponsa in rare leukaemia following review
August 9, 2018Sales and Marketing NICE, Pfizer, leukaemia, pharma
Pfizer has revealed that NICE has finally decided to recommend its CD22-targeting monoclonal antibody Besponsa (inotuzumab ozogamicin) in the treatment …
Pfizer to consider stockpiling medicines in preperation for no-deal Brexit
August 6, 2018Sales and Marketing EU, MSD, Pfizer, Sanofi, brexit, stockpiling
Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …
Allergan sues Pfizer over opioid crisis lawsuits
August 3, 2018Medical Communications Allergan, Litigation, Pfizer, lawsuits, opioid crisis, opioids
Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds …
Pfizer notches two EU approvals, including Herceptin biosimilar
August 1, 2018Research and Development, Sales and Marketing Cancer, EMA, EU, Genetech, Herceptin, Pfizer, Trazimera, Xeljanz, biosimilar, breast cancer, pharma
Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …
Pharma CEO Ian Read forcasts rebate-free drug market
August 1, 2018Research and Development CEO, Ian Read, PBMs, Pfizer, Rebates
The CEO of American multinational Pfizer has said that he believes the Trump administration will eliminate rebates on prescription drug …
Top Ten most popular articles on Pharmafile.com this week
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra
With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …
Takeda’s Alunbrig topples Pfizer’s Xalkori in ALK-positive lung cancer
July 27, 2018Medical Communications, Research and Development Alunbrig, Cancer, NSCLC, Pfizer, Takeda, Xalkori, lung cancer, pharma
Takeda has unveiled new Phase 3 data showing that its tyrosine kinase inhibitor (TKI) Alunbrig (brigatinib) not only met its …
Pfizer to build $465m sterile injectable plant in Michigan
July 25, 2018Manufacturing and Production, Research and Development Michigan, Pfizer, US, manufacturing, pharma
Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …
FDA approves Pfizer biosimilar version of Amgen’s Neupogen
July 23, 2018Sales and Marketing Amgen, FDA, Neupogen, Nivestym, Pfizer, pharma
The FDA has announced its decision to approve Pfizer’s Nivestym, the firm’s biosimilar version of Amgen’s Neupogen (filgrastim), for use …
Merck joins Pizer and Novartis in reducing drug prices
July 20, 2018Medical Communications Merck, Novartis, Pfizer, Trump, Twitter, price hikes
Merck & Co. have joined Pfizer and Novartis in halting price increases on medicines in the United States. The American …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
